Leaks that UK Government Concerned about U.S. Vaccine & Drug Hoarding: Looking for Vaccine Deals in Europe

Leaks that UK Government Concerned about U.S. Vaccine & Drug Hording Looking for Vaccine Deals in Europe

GlaxoSmithKline and Sanofi are close to a £500m deal to supply the British government with 60 million doses of their SARS-CoV-2 investigational vaccine. A business department within the UK government seeks an option to procure the vaccine from the two giant “pharmas” should their candidate actually work in human clinical trials which commence in September. That America has been gobbling up Remdesivir supplies heightens Anglo concerns.

American Buying Frenzy

That America’s rapidly buying up of Remdesivir supplies from California-based Gilead may have prompted government official fears that perhaps under the current “wheel and deal” ethos in Washington the UK had best secure other potential supplies, reported The Sunday Times.

Britain’s Second Deal?

Should the UK move forward on this proposed deal this would be its second deal. It has already secured 100 doses of the Oxford/AstraZeneca vaccine, for example. According to The Sunday Times, Sanofi wasn’t’ available for comment and a spokesperson for GSK declined to comment. Meanwhile, a spokeswoman for the UK business ministry was quoted “The Government’s Vaccines Task Force is actively engagin...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee